IEL Limited reported a standalone net profit of ₹57.14 lakh for the quarter ended June 30, 2026, marking a significant turnaround from the net loss of ₹73.75 lakh incurred in the corresponding quarter of the previous fiscal year. The Ahmedabad-based chemical business firm saw its total income rise to ₹88.76 lakh, compared to ₹5.02 lakh in Q1FY25, driven by operational activities and other income contributions. This financial improvement coincides with the company’s ongoing execution of its capital expansion plans funded by a recent rights issue.

The Board of Directors approved the unaudited standalone financial results on August 10, 2026, following a review by the Audit Committee and a limited review by statutory auditors Maark & Associates. In addition to the financial results, the Board approved convening the company’s 70th Annual General Meeting (AGM) for shareholders on September 28, 2026, at 3:00 PM IST via video conferencing. The meeting will address agenda items including the Board’s report for the financial year ended March 31, 2026.

Financial Performance Highlights

IEL Limited’s revenue from operations reached ₹50.00 lakh in Q1FY26, emerging from nil in Q1FY25. Other income increased significantly to ₹38.76 lakh from ₹5.02 lakh in the prior year quarter. Total expenses for the current quarter were ₹12.32 lakh, a sharp decline from ₹78.64 lakh in Q1FY25, largely due to a reduction in other expenses which fell to ₹11.16 lakh from ₹74.44 lakh.

Basic earnings per share (EPS) for continuing operations were ₹0.044 in Q1FY26, compared to a basic loss per share of ₹(0.057) in Q1FY25. For the full fiscal year FY25, the company had reported a net profit of ₹18.46 lakh on total income of ₹137.14 lakh.

Rights Issue Utilization Status

The company provided an update on the utilization of funds raised through its rights issue, which closed on March 5, 2025. IEL Limited raised a total of ₹43,17,21,894.20, with net proceeds of ₹42,69,55,905.50 available for utilization after deducting issue-related expenses of ₹47,65,988.70. As of June 30, 2026, the company has utilized ₹1,902.91 lakh of these proceeds.

The funds were allocated towards acquiring land for warehouse construction (₹977.00 lakh fully utilized), meeting general corporate purposes (₹925.91 lakh fully utilized), and financing the construction of warehouses. The latter object, allocated ₹2,414.31 lakh, remains entirely unutilized as of the reporting date. Statutory auditors Maark & Associates certified that there has been no deviation or variation in the use of funds from the objects stated in the offer document dated January 17, 2025.

What the Numbers Show

The shift from a net loss to a net profit in Q1FY26 is driven more by cost containment than top-line expansion. While revenue from operations emerged from nil to ₹50.00 lakh, the most significant contributor to the bottom-line turnaround was the drastic reduction in 'other expenses,' which fell from ₹74.44 lakh in Q1FY25 to ₹11.16 lakh in Q1FY26. This suggests that the prior year's loss was heavily influenced by one-off or non-recurring costs that did not repeat in the current quarter. Furthermore, the substantial 'other income' of ₹38.76 lakh indicates that non-operating sources continue to play a critical role in the company's profitability profile, accounting for nearly 44% of total income in this quarter.

IEL Limited has closed its trading window for designated persons and their immediate relatives effective July 1, 2026. The closure is in accordance with the company's Code of Conduct for Regulating, Monitoring, Preventing and Reporting of Trading by Designated Persons pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will remain shut until 48 hours after the declaration of the Un-Audited Standalone Financial Results for the quarter ending June 30, 2026.

During this period, employees, directors, key managerial personnel, and designated persons, along with their immediate relatives, are prohibited from trading in the company's equity shares. The restriction is a standard compliance measure implemented ahead of financial result announcements to prevent insider trading.

The company has not yet announced the specific date for the board meeting where the Un-Audited Standalone Financial Results for the quarter ending June 30, 2026, will be considered and declared. This information will be intimated to the exchanges at a later date.

The intimation was submitted to BSE Limited on June 23, 2026, by Ajay B. Gupta, Managing Director of IEL Limited. The company's BSE scrip code is 524614, and it trades under the symbol INDXTRA.